Health Catalyst Valuation
| HCAT Stock | USD 8.13 0.47 6.14% |
At this time, the firm appears to be undervalued. Health Catalyst retains a regular Real Value of $9.41 per share. The prevalent price of the firm is $8.13. Our model calculates the value of Health Catalyst from evaluating the firm fundamentals such as return on asset of -0.0526, and Return On Equity of -0.21 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Health Catalyst's valuation include:
Price Book 1.2614 | Enterprise Value 424.9 M | Enterprise Value Ebitda (4.96) | Price Sales 1.543 | Forward PE 21.0084 |
Undervalued
Today
Please note that Health Catalyst's price fluctuation is somewhat reliable at this time. Calculation of the real value of Health Catalyst is based on 3 months time horizon. Increasing Health Catalyst's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Health Catalyst's intrinsic value may or may not be the same as its current market price of 8.13, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.13 | Real 9.41 | Target 14.67 | Hype 8.1 | Naive 7.58 |
The intrinsic value of Health Catalyst's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Health Catalyst's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Health Catalyst helps investors to forecast how Health stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Health Catalyst more accurately as focusing exclusively on Health Catalyst's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Health Catalyst's intrinsic value based on its ongoing forecasts of Health Catalyst's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Health Catalyst's closest peers.
Health Catalyst Cash |
|
Health Valuation Trend
Health Catalyst's real value is important for investors to make better decisions and a more accurate overall view of Health Catalyst's financial worth over time. Using both Health Catalyst's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Health Catalyst Total Value Analysis
Health Catalyst is currently forecasted to have valuation of 424.91 M with market capitalization of 466.09 M, debt of 249.07 M, and cash on hands of 403.35 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Health Catalyst fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
424.91 M | 466.09 M | 249.07 M | 403.35 M |
Health Catalyst Investor Information
About 91.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.26. Some equities with similar Price to Book (P/B) outperform the market in the long run. Health Catalyst recorded a loss per share of 1.34. The entity had not issued any dividends in recent years. Based on the key indicators related to Health Catalyst's liquidity, profitability, solvency, and operating efficiency, Health Catalyst is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Health Catalyst Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Health Catalyst has an asset utilization ratio of 42.17 percent. This implies that the Company is making $0.42 for each dollar of assets. An increasing asset utilization means that Health Catalyst is more efficient with each dollar of assets it utilizes for everyday operations.Health Catalyst Ownership Allocation
Health Catalyst has a total of 60.85 Million outstanding shares. The majority of Health Catalyst outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Health Catalyst to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Health Catalyst. Please pay attention to any change in the institutional holdings of Health Catalyst as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Health Catalyst Profitability Analysis
The company reported the previous year's revenue of 295.94 M. Net Loss for the year was (118.15 M) with profit before overhead, payroll, taxes, and interest of 135.56 M.About Health Catalyst Valuation
The stock valuation mechanism determines Health Catalyst's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Health Catalyst based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Health Catalyst. We calculate exposure to Health Catalyst's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Health Catalyst's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 131.8 M | 99.8 M | |
| Pretax Profit Margin | (0.40) | (0.42) | |
| Operating Profit Margin | (0.43) | (0.45) | |
| Net Loss | (0.40) | (0.42) | |
| Gross Profit Margin | 0.45 | 0.38 |
Health Catalyst Growth Indicators
Investing in growth stocks can be very risky. If the company such as Health Catalyst does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 56.4 M | |
| Forward Price Earnings | 21.0084 |
Health Catalyst Current Valuation Indicators
Health Catalyst's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Health Catalyst's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Health Catalyst, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Health Catalyst's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Health Catalyst's worth.Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.